Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2026 highlights: Astra, CSPC sign up to US$ 18.5 bn obesity deal; Wegovy’s pill version debuts in US

    Stock Recap
    #PipelineProspector

    Menu

    Novartis brand of xylometazoline hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 520Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    27/02/2026 Siegfried AG
    Switzerland
    		 Johnson & Johnson Korea Sales Co., Ltd. 20130806-189-I-304-02(2) xylometazoline hydrochloride 2024-07-17 Siegfried PharmaChemikalien Minden GmbH Germany Karlstrasse 15-39, 42-44, 32423 Minden, North Rhine-Westphalia, Germany
    27/02/2026 Siegfried AG
    Switzerland
    		 Heilion Korea Co., Ltd. 20120601-189-I-31-01 Xylometazoline hydrochloride 2012-06-01 BASF Pharma (Evionnaz) SA Switzerland Route du Simplon 1, 36, 1902 Evionnaz, Switzerland
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.